Opioids
The Senate Judiciary Committee today approved five bills to address the opioid crisis, which include provisions aimed at increasing participation in drug take-back programs, strengthening Drug Enforcement Administration discretion in setting opioid quotas, and reducing demand for illicit narcotics.
The Senate Finance Committee yesterday introduced 22 bipartisan bills to address the opioid crisis in Medicare, Medicaid and human services programs.
As we reflect on and commemorate Mental Health Month, one thing is clear: shining a light on mental health and substance use disorders (SUD) does not exacerbate these conditions; it helps dissolve the stigma often attached to them.
The Food and Drug Administration has approved special handling instructions to allow health care providers to use certain opioid and other intravenous drug products made by Hospira that were on hold due to low potential for a manufacturing defect but are in short supply.
The AHA today expressed support for the Opioid Workforce Treatment Act of 2018 (H.R. 5818/S. 2843), bipartisan, bicameral legislation that would reduce the shortage of opioid treatment providers by increasing the number of Medicare-funded residency slots in hospitals with programs focused on…
AHA to Sens. Nelson, Heller expressing support for S. 2843, the Opioid Workforce Treatment Act of 2018.
AHA letter to Representatives Crowley and Costello expressing support for H.R. 5818, the Opioid Workforce Treatment Act of 2018.
The House Energy and Commerce Committee yesterday approved 32 bills to address the opioid crisis, including 12 AHA-supported bills.
The House Energy and Commerce Committee today approved more than 20 bills to address the opioid crisis.
The AHA and seven other national hospital organizations yesterday voiced strong support for legislation that would allow states to receive federal matching funds for services provided to a Medicaid beneficiary with a substance use disorder in an Institution for Mental Disease.